Breath Freely.
Live Life without Drugs

Spiro Medical is redefining respiratory therapeutics at the neural interface-offering the first drug-free alternative for patients whose lives have been limited by severe asthma and other chronic airway diseases.

Neuromodulation involves the delivery of mild electrical impulses to the brain, spinal cord or peripheral nerves. Neuromodulation therapies, such as deep brain stimulation, transcranial magnetic stimulation, vagus nerve stimulation, peripheral nerve stimulation, and spinal cord stimulation have provided significant clinical benefit to patients with various neurological diseases and pain for decades.

Spiro Medical is revolutionizing the treatment paradigm for patients with severe, chronic airway diseases with no known cures like asthma, chronic cough and COPD. Our clinical results demonstrate that the Spiro Neuromodulation System delivers consistent, measurable and durable disease control without the need for medications.

Spiro Neuromodulation System:
Revolutionary, patented, clinical proven, drug-free treatment without side effects

Out-Patient Procedure
Immediate Life-Changing Results

Neuromodulation leads to continuous bronchodilation, decreased mucous formation and inhibition of airway hyperresponsiveness – without the need for medications.

Our Pipeline

Asthma

    

Refractory Chronic Cough

    

COPD

    

Spiro Neuromodulation Provides a Significant Value-based Clinical Benefit for Patients, Families and the Healthcare System

  • Drug-free asthma control
  • Eliminates exacerbations, ER visits, hospitalizations, lost productivity
  • Reduces/eliminates daily asthma medication use and associated side effects
  • Improves lung function
  • Improves Quality of Life
  • Significant cost savings for healthcare system
  • Reimbursement in place

Experienced Management Team

Dr. Kurt Gehlsen

Chief Executive Officer,
Director

Stephen Pyles, MD

Founder, Chief Medical
Officer, Director

Brian Mooney

Chief Financial Officer

Michael Guarino

Chairman of the Board

Dr. Kurt Gehlsen

Chief Executive Officer,
Director

Highly experienced Venture Investor and Senior Executive with 35+ years’ experience in start-ups, private and public companies, Pharma, company formation and growth, technology and company investments, pharmaceutical and medical device product development, leadership positions in basic research, clinical development, regulatory affairs, strategic exits, business development, licensing and executive management.

Stephen Pyles, MD

Founder, Chief Medical Officer, 
Director

World renowned physician inventor and entrepreneur. Inventor on over 15 patents. 39 years’ experience as a pain management physician including an early adopter of neuromodulation, implanting over 3,500 patients in his career. Advisor to large strategics including Boston Scientific, Medtronic, and Abbott.

Brian Mooney

Chief Financial Officer

Brian Mooney has 30+ years of senior management experience in life sciences, software, and finance, serving as CFO and COO. Brian led a venture lending fund and boutique merchant bank, closing diverse transactions. He holds degrees from Trinity College Dublin and Smith School of Business, University of Maryland (BA in Finance and MBA).

Michael Guarino

Chairman of the Board

Michael A Guarino is an accomplished healthcare business leader with a track record in managing surgery centers, serving as a CFO for a medical device company, and growing an independent physician group to over 3,500 doctors in New York. As the founder and President of Practice Management America, he achieved a lucrative exit, leaving a lasting impact in healthcare, establishing him as a standout leader.